CAS 2035008-70-7

Levilimab

CAS: 2035008-70-7

Levilimab (BCD-089) is a fully humanized human monoclonal antibody targeting membrane-bound and soluble IL-6 R for the study of rheumatoid arthritis.

Purezza: 97.8% (SDS-PAGE); 97.3% (SEC-HPLC) - 97.8% (SDS-PAGE); 97.3% (SEC-HPLC)

Colore e forma: Liquid

Peso molecolare: 145.69 kDa

Ref: TM-T77062

Levilimab

CAS: 2035008-70-7

A fully human anti-interleukin-6 receptor (IL-6R) monoclonal antibody.

Ref: 3D-CLA1548